Neurology
Eisai and Biogen’s Leqembi® Secures First-of-Its-Kind EU Authorization for Early Alzheimer’s
Eisai Co., Ltd. and Biogen Inc. announced today that the European Commission (EC) has granted the amyloid-beta (Aβ) monoclonal antibody Leqembi® (...
April 21, 2025 | News
Brain Navi Initiates IPO Counseling with First Securities to Accelerate Growth in AI-Driven Surgical Robotics
Brain Navi Biotechnology Co., Ltd. ("Brain Navi") has officially begun IPO counseling with First Securities Inc., marking a strategic step toward acce...
April 18, 2025 | News
XellSmart Receives IND Approval from FDA for iPSC-Derived Cell Therapy in Parkinson’s Disease
In January 2025 (U.S. time), the U.S. Food and Drug Administration (FDA) officially approved the Investigational New Drug (IND) application submi...
April 16, 2025 | News
CAS and Cleveland Clinic Join Forces to Accelerate Drug Discovery and Brain Health Research
CAS, a division of the American Chemical Society specializing in scientific content and knowledge management, and Cleveland Clinic, an academic ...
April 08, 2025 | News
ABL Bio and GSK Sign Multi-Program Licensing Deal to Develop Neurodegenerative Therapies Using Grabody-B Platform
ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases - Programs will leverage ABL...
April 07, 2025 | News
Luye Pharma’s Twice-Weekly Rivastigmine Patch Approved in Japan for Alzheimer’s
Luye Pharma Group announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the Japa...
April 01, 2025 | News
Shanghai ArkBio Completes Phase III Trial of AK0901 for Pediatric ADHD in China
Shanghai Ark Biopharmaceutical Co., Ltd. announced the successful completion of the Phase III clinical study of AK0901, a novel drug for the treatment of a...
March 25, 2025 | News
Alamar Biosciences Launches NULISAseq Mouse Panel 120 to Power Precision Biomarker Discovery in Preclinical Research
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of the NULISAseq M...
March 26, 2025 | News
Harbour BioMed and Insilico Medicine Partner to Accelerate AI-Driven Antibody Discovery
Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on...
February 21, 2025 | News
Andelyn Biosciences Expands AAV Curator™ Platform with Broad Institute’s CNS Capsids to Advance Gene Therapy for Neurological Diseases
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has expand...
February 21, 2025 | News
Paradromics and Saudi Arabia’s NEOM Partner to Transform Brain-Computer Interface Therapies
Paradromics, Inc., a global leader in high-data rate brain-computer interface (BCI) technology, announced a strategic investment from NEOM, the sustainable...
February 13, 2025 | News
Thermo Fisher Scientific Introduces Invitrogen™ EVOS™ S1000 for Advanced Spatial Tissue Imaging
Thermo Fisher Scientific Inc., the world leader in serving science, introduced the Invitrogen™ EVOS™ S1000 Spatial Imaging System. This advance...
February 13, 2025 | News
WHO Grants ‘Emestedastat’ as the Official INN for Actinogen’s Xanamem®, a First-in-Class Cortisol Regulator
Actinogen Medical Limited (ASX: ACW) has announced that the World Health Organization (WHO) has granted the nonproprietary name ‘emestedastat...
February 06, 2025 | News
Argent BioPharma’s CannEpil® Offers New Hope for Drug-Resistant Epilepsy Patients
Argent BioPharma Limited (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company, is pioneering a transformative approach to drug-resistant e...
February 06, 2025 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
